Skip to content

CLLS

Cellectis SA

NASDAQ · Healthcare · Biotechnology · FR

$1.18
+7.85%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
1.05x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
2.88x
Price / sales
2.09x
Price / cash flow
-2.83x

Enterprise value

Enterprise value
$36.1M
EV / sales
0.64x
EV / EBITDA
-0.65x
EV / EBIT
-0.58x
Market cap
$118.4M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026